Semaglutide achieves roughly 40-50%
Based on Phase 2 trial data (Jastreboff et al., NEJM , 2023), the most commonly reported adverse effects of retatrutide include: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (most frequent, particularly during dose escalation) Injection site reactions: Redness, bruising, or mild discomfort Decreased appetite: Generally considered a therapeutic effect but can contribute to nutritional deficiency if severe Increased heart rate: Observed with glucagon receptor agonism
Look for clinical studies and real research not sponsored social-media posts and too-good-to-be-true before-and-after photos. She recommends Nutrafol, which has been clinically shown to improve hair growth and density
Self-experimentation with drug dosages, such as microdosing, should be avoided
Higher targets have been proposed during strength training of 1.21.7 g/kg body weight/day [153,154]
Biomarkers can help quantify risk, track response, and support individualized nutrition planning (precision nutrition), but the field is still working out which markers truly improve outcomes beyond standard guidance